Virus-Like Particles (VLPs) platform for the development of an effective melanoma vaccine
Melanoma is the least common type of skin-cancer but the deadliest one. Cancer immunotherapy is considered a powerful tool in cancer treatment. Nevertheless, therapeutic cancer vaccines have led so far to modest immune responses with little clinical impact. The first part of this work is focused on...
| Main Author: | |
|---|---|
| Other Authors: | |
| Published: |
University of Oxford
2018
|
| Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.757868 |